Marinomed Biotech AG buy Savour
Start price
06.03.21
/
0%
€143.00
Target price
06.03.22
-
Performance (%)
-37.76%
End price
21.12.21
€89.00
Summary
This prediction ended on 21.12.21 with a price of €89.00. The BUY prediction by Savour for Marinomed Biotech AG performed very badly with a performance of -37.76%. This prediction was marked as speculative and is excluded from Savour's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Marinomed Biotech AG | - | - | - | - |
iShares Core DAX® | 1.280% | 1.320% | 13.605% | 15.782% |
iShares Nasdaq 100 | -2.457% | -5.192% | 25.941% | 38.434% |
iShares Nikkei 225® | -2.006% | -1.389% | 8.973% | 6.570% |
iShares S&P 500 | -0.662% | -1.884% | 23.684% | 39.611% |
According to Savour what are the pros and cons of Marinomed Biotech AG for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Savour for this prediction
In the thread Marinomed Biotech AG diskutieren
Buy Marinomed Biotech AG